Supporting the

Neuroendocrine Cancer Community

‘Landmark’ liver cancer treatment found to boost survival rate in nearly 90% of patients

Apr 4, 2022

The procedure being pioneered in the UK involves using two small balloons to divert blood past the liver for an hour while delivering drugs directly into the organ – with the average length of survival among those studied found to be 15 months.

Read more – https://news.sky.com/story/landmark-liver-cancer-treatment-found-to-boost-survival-rate-in-nearly-90-of-patients-12581307